Bioactivity:

Lirimilast is an effective, selective, and orally active phosphodiesterase-4 (PDE4) inhibitor (IC50: 49 nM). Lirimilast has potently anti-inflammatory properties. Lirimilast can be used for the treatment of asthma or chronic obstructive pulmonary disease.

CAS nr:

329306-27-6

Purity:

98%

Molecular Weight:

443,26

SMILES:

O=C(N)NC1=C(C(C2=CC=C(Cl)C=C2Cl)=O)OC3=CC(OS(=O)(C)=O)=CC=C13

Formula:

C17H12Cl2N2O6S

Pathway:

Metabolism

Target:

PDE